Skip to content

The Neurobehavioral Effects of Anesthetics on Infants With Hearing Impairment

Long Term Neurobehavioral Effects of Anesthetics and Cochlear Implantation on Infants With Hearing Impairment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04255485
Enrollment
52
Registered
2020-02-05
Start date
2019-04-08
Completion date
2021-12-31
Last updated
2020-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long Term Neurobehavioral Effects

Keywords

infant, anesthesia, neurobehavioral development

Brief summary

The long-term effect of general anesthesia on developing brain is the focus of clinicians when infants exposed to general anesthesia for a long time during operation. A retrospective study showed that children exposed to long-term or repeated operations, the anesthetics had a higher incidence of cognitive impairment in adolescence than those did no. When infants with hearing impairment undergo bilateral cochlear implant surgery, they are at high risk of long-term neurobehavioral abnormalities caused by anesthesia. In this study, investigators intend to observe the long-term behavioral abnormalities of hearing-impaired infants after unilateral or bilateral cochlear implantation.

Interventions

None listed

Sponsors

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
6 Months to 2 Years

Inclusion criteria

1. Infants aged between 6 months and 2 years old undergoing cochlear implantation under general anesthesia in 9th hospital 2. Patients who have not participated in other clinical trials 3. ASA class I-II selective operation without any acute infectious diseases or systematic diseases 4. Infant's family members agree to participated in the trials and sign the informed consent

Exclusion criteria

1. Reject to sign the informed consent and participate in the trials 2. Patients with severe liver and kidney damage or other heart, lung and nervous system diseases 3. The Gesell developmental scale is less than 86 in motor behavior and physical energy 4. With a history of intrauterine distress, umbilical cord around the neck, hypoxia and jaundice 5. Infant who is allergic to egg and milk 6. Family history of malignant hyperthermia 7. Allergy to anesthetic drugs

Design outcomes

Primary

MeasureTime frameDescription
change of Baseline Gesell Developmental Scale after 6 monthchange in 6 months after surgeryNeurobehavior effects

Secondary

MeasureTime frameDescription
change of Baseline Gesell Developmental Scale after 12 monthchange in 12 months after surgeryNeurobehavior effects

Countries

China

Contacts

Primary ContactJingjie Li, M.D
116212@sh9hospital.org86-18019790516
Backup ContactLei Zhang, Ph.D

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026